GUGGENHEIM CAPITAL LLC – Regeneron Pharmaceuticals, Inc. Transaction History
GUGGENHEIM CAPITAL LLC portfolio value:
$37.55M
portfolio value
GUGGENHEIM CAPITAL LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -13.07% | -8.19K shares | 483K | $688.87 | 54.51K |
Q2 2022 | share | Decrease | -6.11% | -4.07K shares | -9.57M | $591.13 | 62.71K |
Q1 2022 | share | Decrease | -13.97% | -10.84K shares | -2.38M | $698.42 | 66.79K |
Q4 2021 | share | Increase | +10.17% | 7.16K shares | 6.38M | $642.51 | 77.63K |
Q3 2021 | share | Decrease | -11.29% | -8.97K shares | -1.72M | $605.18 | 70.47K |
Q2 2021 | share | Increase | +16.66% | 11.34K shares | 12.15M | $558.54 | 79.44K |
Q1 2021 | share | Increase | +4.53% | 2.95K shares | 745K | $473.14 | 68.10K |
Q4 2020 | share | Decrease | -0.11% | -70 shares | -5.03M | $483.11 | 65.15K |
Q3 2020 | share | Decrease | -6.43% | -4.48K shares | -6.96M | $559.78 | 65.22K |
Q2 2020 | share | Decrease | -7.46% | -5.61K shares | 6.69M | $623.65 | 69.70K |
Q1 2020 | share | Decrease | -15.85% | -14.18K shares | 3.17M | $488.29 | 75.32K |
Q4 2019 | share | Increase | +0.80% | 706 shares | 8.97M | $375.48 | 89.50K |
Q3 2019 | share | Increase | +26.79% | 18.76K shares | 2.71M | $277.4 | 88.79K |
Q2 2019 | share | Increase | +4.18% | 2.80K shares | -5.68M | $313 | 70.03K |
Q1 2019 | share | Increase | +9.99% | 6.10K shares | 4.77M | $410.62 | 67.22K |
Q4 2018 | share | Decrease | -14.54% | -10.40K shares | -6.07M | $373.5 | 61.12K |
Q3 2018 | share | Decrease | -3.27% | -2.41K shares | 3.39M | $404.04 | 71.52K |
Q2 2018 | share | Decrease | -66.34% | -145.74K shares | -50.14M | $344.99 | 73.93K |
Q1 2018 | share | Increase | +1.08% | 2.35K shares | -6.05M | $344.36 | 219.68K |
Q4 2017 | share | Increase | +35.41% | 56.82K shares | 9.94M | $375.96 | 217.33K |
Q3 2017 | share | Increase | +0.19% | 297 shares | -6.91M | $447.12 | 160.50K |
Q2 2017 | share | Decrease | -5.61% | -9.52K shares | 12.90M | $491.14 | 160.20K |
Q1 2017 | share | Increase | +3.50% | 5.74K shares | 5.57M | $387.51 | 169.73K |
Q4 2016 | share | Decrease | -19.94% | -40.84K shares | -22.14M | $367.09 | 163.98K |
Q3 2016 | share | Increase | +2.81% | 5.59K shares | 12.76M | $402.02 | 204.83K |
Q2 2016 | share | Increase | +4.13% | 7.90K shares | 616K | $349.23 | 199.24K |
Q1 2016 | share | Decrease | -7.56% | -15.64K shares | -43.39M | $360.44 | 191.33K |